Skip to main content
. Author manuscript; available in PMC: 2021 Mar 3.
Published in final edited form as: JAMA. 2020 Mar 3;323(9):819–820. doi: 10.1001/jama.2019.20504

Figure.

Figure.

Generic Drug Manufacturing and Purchasing System

Notes: Abbreviations: FDA=Food and Drug Administration; ANDA=Abbreviated New Drug Application. The figure depicts the generic drug manufacturing and purchasing system, including regulatory approval provided by the FDA; the joint manufacturing enterprise of generic sponsors who hold ANDAs, suppliers of active ingredients and contract manufacturing organizations; drug purchasing by health systems and pharmacies who often go through intermediaries such as group purchasing organizations or wholesalers; and ultimately reimbursement that flows from patients and payers (e.g., insurance companies, Medicare) to the health systems and pharmacies that administer or dispense drugs to patients. Solid arrows indicate the direction of the flow of generic drug products or services, and dotted arrows the flow of payment.